Loading people...
Claire Brown is a Partner at Oxford Science Enterprises based in Oxford, United Kingdom. Prior to her current position, she served as an Investment Director and held fund management roles at IP Group and other early-stage venture capital firms. With over 15 years of industry experience, she helps deploy capital from a substantial funding pool that has raised over £800 million to support more than 50 growing companies. Her portfolio management includes notable exits such as the 2021 initial public offering of Vaccitech and recent investments in quantum computing spin-outs. She holds a doctorate in chemistry from the University of Oxford and an undergraduate degree from the University of Cambridge. Brown currently focuses on commercializing academic research by scaling deep technology, artificial intelligence, and life sciences ventures from seed to Series A funding.
Claire Brown serves as a distinguished Partner at Oxford Science Enterprises (OSE), a unique venture firm with a mission to transform scientific discoveries from Oxford University into successful, impactful companies. In her pivotal role, Claire is instrumental in the entire investment lifecycle, from initial scouting and due diligence to providing strategic support for portfolio companies as they scale.
Oxford Science Enterprises is renowned for its deep commitment to commercializing cutting-edge research across various sectors. Claire's investment focus aligns perfectly with OSE's mandate, primarily targeting opportunities within deep technology and life sciences. This includes areas such as novel therapeutics, advanced diagnostics, artificial intelligence applied to healthcare, quantum computing, advanced materials, and sustainable technologies. Her expertise helps bridge the gap between academic innovation and market readiness, ensuring that promising scientific breakthroughs receive the necessary capital and guidance to flourish.
Claire's career background is deeply rooted in both science and venture capital, providing her with a comprehensive understanding of the challenges and opportunities inherent in deep tech and life science investments. She holds a PhD in Chemistry from the University of Oxford, a testament to her strong scientific foundation. Prior to joining Oxford Science Enterprises, Claire honed her skills at IP Group plc, a leading intellectual property commercialization company. There, she gained invaluable experience in investing in university spinouts and developing early-stage technology companies, further solidifying her expertise in translating academic research into commercial success.
While specific individual notable investments are often attributed to the OSE fund as a whole rather than individual partners publicly, Claire's work directly contributes to the firm's impressive portfolio of companies. These ventures are at the forefront of innovation, tackling some of the world's most pressing challenges in health, technology, and sustainability. Her strategic insights and scientific acumen are vital in identifying the next generation of industry leaders emerging from Oxford's vibrant research ecosystem, making her a key figure in the UK's deep tech and life sciences venture landscape.
Through her dedication and expertise, Claire Brown continues to drive the growth of groundbreaking companies, reinforcing Oxford Science Enterprises' position as a powerhouse in university commercialization and venture capital.
Claire Brown is a Partner at Oxford Science Enterprises, a venture firm focused on commercializing scientific research from Oxford University. She specializes in deep technology and life sciences investments.
Claire Brown invests in deep technology and life sciences ventures, including novel therapeutics, advanced diagnostics, AI in healthcare, quantum computing, and advanced materials, all emerging from Oxford University research.
Claire Brown works as a Partner at Oxford Science Enterprises, a leading venture capital firm based in Oxford, UK, dedicated to building businesses from Oxford University's scientific discoveries.
